Biomerica Stock Revenue
| BMRA Stock | USD 0.60 0.07 13.21% |
Biomerica fundamentals help investors to digest information that contributes to Biomerica's financial success or failures. It also enables traders to predict the movement of Biomerica Stock. The fundamental analysis module provides a way to measure Biomerica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomerica stock.
Biomerica |
Biomerica Company Revenue Analysis
Biomerica's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Biomerica Revenue | 5.34 M |
Most of Biomerica's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomerica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Biomerica reported 5.34 M of revenue. This is 99.93% lower than that of the Health Care Equipment & Supplies sector and 99.79% lower than that of the Health Care industry. The revenue for all United States stocks is 99.94% higher than that of the company.
Biomerica Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomerica's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomerica could also be used in its relative valuation, which is a method of valuing Biomerica by comparing valuation metrics of similar companies.Biomerica is currently under evaluation in revenue category among related companies.
Biomerica Fundamentals
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.43 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (1.97) % | ||||
| Current Valuation | 4.5 M | ||||
| Shares Outstanding | 16.82 M | ||||
| Shares Owned By Insiders | 7.30 % | ||||
| Shares Owned By Institutions | 26.72 % | ||||
| Number Of Shares Shorted | 65.81 K | ||||
| Price To Earning | (25.64) X | ||||
| Price To Book | 1.48 X | ||||
| Price To Sales | 2.58 X | ||||
| Revenue | 5.34 M | ||||
| Gross Profit | 446 K | ||||
| EBITDA | (6.87 M) | ||||
| Net Income | (7.14 M) | ||||
| Cash And Equivalents | 6.08 M | ||||
| Cash Per Share | 0.45 X | ||||
| Total Debt | 1.08 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 5.22 X | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (5.47 M) | ||||
| Short Ratio | 0.94 X | ||||
| Earnings Per Share | (0.37) X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 62 | ||||
| Beta | -1.04 | ||||
| Market Capitalization | 8.96 M | ||||
| Total Asset | 14.45 M | ||||
| Retained Earnings | (42.22 M) | ||||
| Working Capital | 10.85 M | ||||
| Current Asset | 4.77 M | ||||
| Current Liabilities | 445 K | ||||
| Net Asset | 14.45 M |
About Biomerica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomerica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomerica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomerica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biomerica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomerica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will appreciate offsetting losses from the drop in the long position's value.Moving together with Biomerica Stock
| 0.69 | DHR | Danaher Earnings Call This Week | PairCorr |
Moving against Biomerica Stock
| 0.62 | GCTK | GlucoTrack | PairCorr |
| 0.62 | SNDA | Sonida Senior Living | PairCorr |
| 0.61 | VALN | Valneva SE ADR Earnings Call This Week | PairCorr |
| 0.53 | JYNT | Joint Corp Financial Report 2nd of May 2024 | PairCorr |
| 0.51 | TNDM | Tandem Diabetes Care | PairCorr |
The ability to find closely correlated positions to Biomerica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomerica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomerica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomerica to buy it.
The correlation of Biomerica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomerica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomerica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomerica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biomerica Piotroski F Score and Biomerica Altman Z Score analysis. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.